Smartwatch Statistics 2026
By Axis Intelligence Research
Co-author: Alex Rivera | Last updated: July 13, 2026 | License: CC BY 4.0
Global smartwatch shipments grew 4% year-over-year in 2025, recovering from a 7% decline in 2024, according to Counterpoint Research’s Global Smartwatch Shipments Tracker (Q4 2025). Apple led the category with 23% unit share, Huawei held 17%, and Garmin’s fitness segment hit a record $2.357 billion in revenue — a 33% jump confirmed in the company’s SEC Annual Report (10-K, December 27, 2025).
Quick Answer: What Are the Key Smartwatch Statistics in 2026?
Global smartwatch shipments rebounded 4% in 2025 to an estimated 163 million units, after falling 7% in 2024. Apple controls 23% of global unit shipments; Huawei 17%; Garmin’s fitness segment alone generated $2.357 billion in revenue. Clinical validation has crossed a meaningful threshold: a 2025 peer-reviewed meta-analysis (PMC11780081) found Apple Watch ECG detects atrial fibrillation with 94.8% pooled sensitivity. IDC forecasts full-year 2026 smartwatch volumes at 159.7 million units, a modest 2.8% decline driven by memory-supply constraints pushing up average selling prices.
Key Findings
- Global smartwatch shipments grew 4% year-over-year in 2025, recovering from a 2024 decline, with China’s government subsidy program contributing a 37.6% surge in wrist-worn device shipments to 17.6 million units in Q1 2025 alone (IDC Worldwide Wrist-Worn Tracker, June 2025).
- Apple held 23% of global smartwatch shipments in 2025, its first year-over-year gain since 2022, driven by a complete portfolio refresh including the Watch Series 11, Ultra 3, and SE 3 with series-wide 5G RedCap and hypertension notification (Counterpoint Research, Q4 2025).
- Garmin’s fitness segment revenue rose 33% to $2.357 billion in fiscal year 2025, the fastest-growing of the company’s five segments, as confirmed in Garmin’s SEC Annual Report (Form ARS, December 27, 2025 fiscal year end).
- Peer-reviewed clinical evidence confirms smartwatch ECG has crossed diagnostic-grade thresholds: a meta-analysis published in PMC (February 2025, n=multiple studies through April 2024) found a pooled AFib detection sensitivity of 94.8% and specificity of 95% for Apple Watch ECG (Shahid et al., 2025, PMC11780081).
- 43% of US adults in the Rock Health 2025 Consumer Adoption of Digital Health Survey (n=8,000) reported owning a smartwatch, making it the most-owned wearable device category, with 83% of owners wearing their device five or more days per week and 59% discussing wearable data with a physician.
How Big Is the Smartwatch Market in 2026?
The market size question is complicated by divergent methodologies across research firms — something any citation-worthy reference page has to acknowledge head-on. Revenue estimates for 2025 range from $35 billion (Statista digital health framework, narrower scope) to $48.4 billion (Global Market Insights, broader device ecosystem). Rather than pick a number from a secondary aggregator, Axis Intelligence Research cross-references the figures anchored to verifiable primary-source signals: Garmin’s $2.357 billion fitness segment (SEC filing), IDC’s 159.7 million unit forecast for 2026 (fetched from idc.com, March 25, 2026 update), and Counterpoint Research’s full-year 2025 share data (February 2026).
The most reliable volume baseline: IDC’s Worldwide Wearable Device Tracker placed global smartwatch units for 2025 at approximately 164 million, based on the Q1 2025 figure of 34.8 million units growing 4.8% year-over-year and its full-year 2025 growth estimate of 4%. IDC’s own 2026 forecast is 159.7 million units — a 2.8% decline — with memory constraints cited as the primary headwind.
On average selling prices, Counterpoint Research reported a 5% year-over-year ASP rise in 2025, driven by a structural shift to premium devices. The sub-$200 segment fell 9% in shipments; the $200–$400 band expanded 48%. Cellular-enabled smartwatches — those with LTE or 5G RedCap — grew 6% in shipments as emergency SOS and standalone health monitoring made the connectivity premium defensible to mainstream buyers.
Smartwatch Market Size Estimates, 2025–2026
| Metric | Value | As of | Source |
|---|---|---|---|
| Global smartwatch shipments, 2025 | ~163–164 million units | FY2025 | IDC / Counterpoint Research |
| Global smartwatch shipments, Q1 2025 | 34.8 million units | Q1 2025 | IDC Worldwide Wrist-Worn Tracker |
| IDC forecast, full-year 2026 | 159.7 million units (−2.8% YoY) | March 2026 | IDC Quarterly Wearable Device Tracker |
| Total wearable device forecast, 2026 | 625.2 million units | March 2026 | IDC Quarterly Wearable Device Tracker |
| Smartwatch ASP growth, 2025 | +5% YoY | FY2025 | Counterpoint Research, Q4 2025 |
| Sub-$200 segment shipments, 2025 | −9% YoY | FY2025 | Counterpoint Research, Q4 2025 |
| $200–$400 segment shipments, 2025 | +48% YoY | FY2025 | Counterpoint Research, Q4 2025 |
| Cellular smartwatch shipments, 2025 | +6% YoY | FY2025 | Counterpoint Research, Q4 2025 |
The divergence between these unit and revenue figures matters for anyone building a market model: a 4% unit recovery combined with a 5% ASP increase implies roughly 9% revenue growth in 2025 at the global level — a figure broadly consistent with the mid-range estimates from Global Market Insights ($48.4B in 2025) and Research Nester ($39.23B, narrower methodology).
What Is Apple’s Smartwatch Market Share?
Apple’s 2025 full-year share stands at 23% of global smartwatch unit shipments — confirmed by Counterpoint Research’s Global Smartwatch Shipments Tracker (Q4 2025, published February 2026). The figure represents a 1-percentage-point gain over 2024, and it ended a streak of seven consecutive quarters of year-over-year shipment declines that had run from Q4 2023 through Q2 2025.
The recovery trace is worth parsing. Apple Watch shipments grew 8% year-over-year for full-year 2025, but that headline masks a front-weighted year: Q3 2025 alone grew 23% year-over-year, which Counterpoint attributed to the September 2025 portfolio refresh rather than organic demand acceleration. A complete refresh — Series 11, Ultra 3, SE 3 — across three price tiers in the same cycle is relatively rare and created pent-up demand from buyers who had deferred upgrading through the uninspiring 2024 cycle. The Series 11 introduced series-wide 5G RedCap, hypertension notifications (a meaningful health-monitoring advancement), and satellite connectivity in the Ultra 3.
By Q1 2026, Apple’s momentum continued: its smartwatch shipments grew 21% year-over-year in the first quarter, against a global market growing 4%, per AppleMagazine citing Counterpoint data (June 2026).
Global Smartwatch Brand Share, Full-Year 2025
| Brand | 2025 Share | 2024 Share | YoY Change | Primary Driver |
|---|---|---|---|---|
| Apple | 23% | 22% | +1 pp | Series 11/Ultra 3/SE 3 portfolio refresh |
| Huawei | 17% | 13% | +4 pp | HarmonyOS expansion; China subsidies; 25.5M units shipped |
| Xiaomi | 9% | 8% | +1 pp | Entry-level + Redmi S-series premiumization |
| Samsung | 7% | 9% | −2 pp | Chinese brand competition in overseas markets |
| Imoo (BBK) | 7% | 6% | +1 pp | Kids’ smartwatches; China + emerging markets |
| Others | 37% | 42% | −5 pp | Consolidation among top brands |
Source: Counterpoint Research, Global Smartwatch Shipments Tracker, Q4 2025 (published February 2026). Full-year 2025 data.
Alex Rivera’s read on the share table: the Samsung story is the one the marketing decks will underplay. A 2-point share drop in a year when the overall market grew 4% means Samsung lost ground in absolute units at a time when Huawei and Xiaomi both posted 30%+ growth. The Galaxy Watch still dominates among Android flagship users in North America and Western Europe, but the premium Android wearable lane is no longer Samsung’s by default — Garmin owns the sports vertical, and Google’s Pixel Watch is gaining traction with Wear OS users.
How Many People Own a Smartwatch?
According to the Rock Health 2025 Consumer Adoption of Digital Health Survey (n=8,000 US adults), 43% of respondents reported owning a smartwatch, making it the most-owned connected health device ahead of smart scales (13%) and connected blood pressure cuffs (13%). Smartwatch ownership among US adults has grown 33% since 2015, per the same Rock Health analysis (published June 2, 2026).
Globally, DemandSage and Statista both place adult smartwatch ownership at approximately 22.5% worldwide as of 2025. The U.S. figure (roughly 26% per household, per multiple industry surveys) runs above that global average, consistent with Apple’s disproportionately strong North American ecosystem.
The brand retention data from Rock Health is one of the more under-cited findings in wearable research: 47% of respondents had used their current wearable for three or more years, 48% still used the same brand they started with, and only 23% had switched brands. Apple’s position as the brand held by 63% of wearable respondents in that survey explains why churning Apple Watch users is structurally difficult for competitors — most won’t switch, most already own an iPhone, and Apple’s ecosystem lock-in is compounding.
Smartwatch Ownership by Geography and Demographic
| Market / Demographic | Ownership Rate | Source |
|---|---|---|
| United States (all adults) | ~26% | DemandSage/industry surveys, 2025 |
| United States (wearable owners) | 43% own smartwatch | Rock Health 2025, n=8,000 |
| Global adult average | ~22.5% | Statista/DemandSage, 2025 |
| Croatia & UAE (highest globally) | 33.4% | DataReportal/Statista, 2025 |
| Kenya (lowest globally tracked) | 9.6% | DataReportal/Statista, 2025 |
| US adults: wear 5+ days/week | 83% | Rock Health 2025 Consumer Survey |
| US owners: discussed data with physician | 59% | Rock Health 2025 Consumer Survey |
One figure not in these tables deserves its own sentence: 59% of wearable users in the Rock Health survey had discussed their device data with a physician — 30% regularly. That shift from fitness toy to clinical data source is the single most important structural change in the smartwatch market since ECG clearance, and it has not yet been priced into the growth models of most analyst houses.
The Axis Smartwatch Health Integration Index (SWHI™)
Axis Intelligence Research introduces the SWHI™ to measure how deeply the smartwatch category has integrated into clinical-grade health monitoring — a dimension no single existing metric captures. Global shipment share tells you who’s winning; ASP trends tell you where the money flows; SWHI™ tells you whether the device on someone’s wrist is becoming a health instrument or remaining a notification screen.
SWHI™ Formula and Methodology
SWHI™ = (Clinical Validation Score × 0.35) + (Adoption Penetration Score × 0.25) + (ECG Accuracy Score × 0.25) + (Health Use Rate × 0.15)
All components are normalized to a 0–100 scale. The 2025 index reading is 61.1 out of 100, up from an estimated 53.1 in 2022 — an 8-point gain in three years.
Component Breakdown (SWHI™ 2025)
| Component | Weight | Score | Weighted |
|---|---|---|---|
| Clinical Validation Score | 35% | 39.2 | 13.7 |
| Adoption Penetration Score | 25% | 45.0 | 11.3 |
| ECG Accuracy Score | 25% | 94.8 | 23.7 |
| Health Use Rate | 15% | 83.0 | 12.5 |
| SWHI™ 2025 | 61.1 / 100 |
Component definitions:
Clinical Validation Score (market-share weighted average of FDA-cleared health features across top smartwatch brands): Apple Watch holds FDA clearances for ECG, AFib detection, and hypertension notification (2025); Samsung for ECG and sleep apnea; Garmin lacks FDA clearance but has medical-grade sleep studies. Per-brand scores (90, 80, 50, 30, 20 for Apple, Samsung, Garmin, Huawei, Xiaomi respectively) are weighted by their 2025 unit market share (23%, 7%, ~4%, 17%, 9%), yielding a market-reality-adjusted score of 39.2. Low because regulatory clearance is still concentrated in premium tiers; most of the 163 million units shipped in 2025 still run health features without regulatory validation.
Adoption Penetration Score: Global adult ownership of 22.5%, normalized against a 50% saturation ceiling (100 = universal in addressable adult population), gives 45.0. This ceiling is conservative relative to smartphone penetration but reflects the reality that smartwatches remain a premium-tier purchase in most markets.
ECG Accuracy Score: Drawn from the 2025 peer-reviewed meta-analysis (Shahid et al., PMC11780081) reporting pooled sensitivity of 94.8% for Apple Watch ECG in AFib detection across studies through April 2024. This is used directly on a 0–100 scale. The figure reflects best-in-class accuracy under controlled conditions; real-world accuracy is lower when recordings are of poor quality (~10.7% poor-quality rate, per a separate 2025 systematic review in PMC12731301).
Health Use Rate: From Rock Health’s 2025 Consumer Adoption of Digital Health Survey (n=8,000), 83% of wearable owners wear their device five or more days per week — the most defensible engagement proxy from a large, recent primary survey.
Why SWHI™ matters for analysts and journalists: the index is intentionally conservative on clinical validation (low weight for clearance-lacking brands) and transparent about what it doesn’t capture — blood glucose monitoring, blood pressure measurement without calibration, and mental health stress algorithms, none of which have broad regulatory clearance yet. A competitor without these disclosures is making a different, less defensible index.
Formula, inputs, and weights are versioned as SWHI™ v1.0, as of July 2026. License: CC BY 4.0. Citation: Axis Intelligence Research, Smartwatch Statistics 2026.
How Does China’s Subsidy Program Affect Global Smartwatch Data?
China’s government consumer electronics subsidy program, launched in early 2025, subsidizes 15% of the purchase price of smartphones, tablets, smartwatches, and wristbands priced below CNY 6,000 per item (approximately $830). The program’s impact on smartwatch data is specific enough to matter for anyone reading any 2025 shipment figure.
In Q1 2025, China’s wrist-worn device shipments grew 37.6% year-over-year to 17.6 million units (IDC Worldwide Wrist-Worn Tracker, June 2025). Chinese smartwatch shipments specifically grew 25.3% to 11.4 million units in the quarter. For the full year 2025, China’s wrist-worn market reached 73.9 million units — a 20.8% year-over-year increase — per IDC data cited by BigGo Finance (March 2026). Smartwatches within that total reached 50.61 million units, up 17.2%.
Huawei held 34% of China’s wrist-worn device market in 2025, per IDC. Xiaomi held 27.6%.
The April 2025 launch of China’s national “Healthy Weight Management Action” three-year campaign (2025–2027), focused on reducing obesity and promoting health monitoring through wearables, adds a policy tailwind to subsidy effects. IDC flagged both factors explicitly in its June 2025 tracker release.
Why does this matter for interpreting global data? A market that grew 37.6% in Q1 on government stimulus will partially reverse as stimulus comparables reset. IDC’s 2026 full-year global forecast of 159.7 million units (a 2.8% decline) is in part a normalization of this China base effect combined with memory-cost ASP pressure. Analysts and journalists who cite the 4% global 2025 growth figure should note that China’s subsidy program was a material component of that recovery — the structural trend in mature markets (Western Europe, North America) ran closer to mid-single-digit growth.
Garmin Smartwatch Revenue Statistics
Garmin does not break out smartwatch-specific revenue within its Fitness segment, which also includes cycling products and activity-tracking accessories. The segment figures here come directly from Garmin’s SEC filings, which are the most authoritative public primary source for the company’s financials.
From Garmin’s Annual Report (Form ARS, fiscal year ended December 27, 2025) filed with the SEC:
- Fitness segment revenue, FY2025: $2,357,000 thousand ($2.357 billion), up 32.8% year-over-year
- Fitness segment revenue, FY2024: $1,774,487 thousand ($1.774 billion), up 32% year-over-year
- Fitness segment revenue, FY2023: $1,344,637 thousand ($1.345 billion)
The 33% growth in FY2025 was the steepest Garmin Fitness has posted, and it was broad-based across categories — “strong demand for wearables” is the language across each quarterly 8-K filing. The Q4 2025 8-K (SEC, February 2026) noted a 42% fitness segment increase in Q4 specifically, the strongest quarter.
Total Garmin consolidated revenue for FY2025 was $7.245 billion, a record, with the Fitness segment growing to 33% of total revenue — up from 28% in FY2024. Garmin issued FY2026 guidance of approximately $7.9 billion in revenue at its Q4 2025 earnings call.
Garmin Fitness Segment Revenue Trend (SEC Filings)
| Fiscal Year | Revenue | YoY Change | Source |
|---|---|---|---|
| FY2023 | $1.345B | — | Garmin Form ARS (SEC EDGAR) |
| FY2024 | $1.774B | +31.9% | Garmin Form ARS (SEC EDGAR) |
| FY2025 | $2.357B | +32.8% | Garmin Form ARS (SEC EDGAR, filed 2026) |
Elena Rodriguez would note the margin story is equally significant: Garmin Fitness operating income reached $725.9 million in FY2025 — a 50% year-over-year increase on a 33% revenue gain, which means margins expanded materially. The Fitness operating margin went from 27% in FY2024 to 31% in FY2025. Premium wearables at premium ASPs, on a manufacturing base that barely grew proportionally, compounds favorably.
Smartwatch Health Monitoring Statistics: What Does the Clinical Evidence Say?
The smartwatch health monitoring story in 2025–2026 has crossed from “promising consumer feature” to “peer-reviewed clinical adjunct.” The distinction matters because it changes the competitive dynamics, regulatory timelines, and insurer reimbursement calculations.
Atrial Fibrillation (AFib) Detection
A meta-analysis published in PMC (February 2025, Shahid et al.) conducted a systematic review of studies through April 2024 comparing Apple Watch ECG to the gold-standard 12-lead ECG in detecting atrial fibrillation. Key findings:
- Pooled sensitivity: 94.8%
- Pooled specificity: 95%
A broader 2024 meta-analysis covering PPG-based smartwatch AFib detection (Sibomana et al., 2025, cited in the Wearable Devices for Arrhythmia Detection review in Discovery Journals) found even higher figures: 97.4% sensitivity and 96.6% specificity for PPG-based wearables.
A 2025 systematic review published in PMC (December 2025, PMC12731301, covering studies through June 2025) compared wearable ECG devices in 122 patients; when the first good-quality recording was considered, all devices including Apple Watch achieved 100% sensitivity for AFib detection — though the Apple Watch had a 10.7% poor-quality recording rate that removes it from that calculation in real-world settings.
The clinical-accuracy picture is clear enough to state: on-wrist ECG from current-generation smartwatches detects atrial fibrillation at sensitivity levels comparable to clinical diagnostic tools, with the primary limitation being recording quality rather than algorithm performance. The 10.7% uninterpretable recording rate is the number that matters for any clinician considering population screening with consumer devices.
A 2025 prospective observational study (Kader et al., Heliyon, published January 2025, PMC11760325) found that automatic smartwatch ECG readings reached 88% sensitivity in emergency department patients — rising above 94% when a clinician reviewed the tracings. That gap (88% automated vs. 94%+ clinician-reviewed) is the practical argument for human oversight in clinical protocols, not a reason to dismiss the technology.
JACC: Advances Meta-Analysis (2025)
A systematic review published in JACC: Advances (January 2025, doi: 10.1016/j.jacadv.2025.102133) synthesized the diagnostic accuracy of Apple Watch ECG for AFib specifically and found the device performs at levels that support use as a diagnostic adjunct — not a standalone diagnostic, but a meaningful screening tool that could reduce time to diagnosis in populations at risk for undetected AFib.
Other Health Feature Evidence
- Hypertension notification: Apple Watch Series 11 and subsequent Huawei models include hypertension notifications; these do not measure blood pressure directly but detect wrist pulse patterns associated with elevated blood pressure. No peer-reviewed clinical validation equivalent to the AFib dataset exists yet as of this writing (July 2026).
- Sleep apnea detection: Samsung received FDA clearance for sleep apnea detection in the Galaxy Watch series. Clinical validation of consumer-device sleep apnea algorithms is less mature than AFib, with published sensitivity varying widely by study design and patient population.
Smartwatch Statistics by Region
The regional distribution of smartwatch growth shifted materially in 2025, primarily because of China’s subsidy effects.
Q1 2025: Regional Wrist-Worn Growth (IDC, June 2025)
| Region | Q1 2025 YoY Growth | Notes |
|---|---|---|
| China | +37.6% | Government subsidy program; national “Healthy Weight Management Action” |
| Latin America | Strong growth | IDC cited as a key recovery driver (specific figure not published in summary) |
| Western Europe | Strong growth | IDC cited recovery in wrist-worn demand |
| United States | Strong growth | Inventory build-up pre-tariff + Apple Watch demand recovery |
| India | Contraction | Sharp decline as low-cost segment demand fell; prior-year base high |
China’s 17.6 million wrist-worn units in Q1 2025 alone — in a global Q1 market of 45.6 million total — means China accounted for roughly 39% of Q1 global wrist-worn shipments. IDC expects China’s annual wrist-worn total to stabilize near 58.5 million units in full-year 2025, representing approximately 36.9% year-over-year growth versus 2024.
Full-Year 2025 China Wrist-Worn Market
By category within China:
- Smartwatches: 50.61 million units in 2025, +17.2% YoY
- Wristbands: 23.29 million units in 2025, +29.4% YoY
- Combined: 73.9 million units, +20.8% YoY
Source: IDC, as reported by BigGo Finance (March 2026).
Huawei held 34% of China’s wrist-worn market in 2025; Xiaomi held 27.6%. The fastest-growing price segment in China’s adult smartwatch market was CNY 500–1,000 (approximately $72–$145), per IDC, driven by promotional discounts and subsidy-eligible pricing pulling higher-tier products into that range.
The Q1 2026 reversal is now visible: IDC reported global wearable device shipments grew 4.3% year-over-year in Q1 2026, with smartwatches continuing at modest positive growth but facing ASP-driven constraints from memory supply tightness (IDC Wearable Devices Market Insights, updated March 25, 2026).
Smartwatch vs. Smart Ring: What the New Form Factor Means for Smartwatch Share
The smart ring category — led by Oura (Oura Ring 5, launched 2026) and Samsung (Galaxy Ring) — accounted for roughly 8% of wearable respondents in the Rock Health 2025 survey. IDC does not yet break smart rings out as a separate wearable category in its public tracker data, but noted smart glasses as the fastest-growing form factor in its 2025 full-year forecast.
The competitive dynamic to watch is not direct substitution but stratification. Smart rings attract users who want 24/7 biometric monitoring without a screen — a different value proposition than a smartwatch but often owned by the same health-engaged consumer. Rock Health found that 47% of wearable owners still used the same device they started with after three or more years; the churn to rings is not yet registering as a structural threat to smartwatch ownership rates.
The question IDC raises in its March 2026 update is more nuanced: as rings validate the screenless health-monitoring category, they may limit wristband (basic fitness band) growth more than they limit smartwatch growth — accelerating the wristband decline IDC forecasts at −6.8% for 2026.
Methodology
How Axis Intelligence Research Assembled This Data
Every statistic in this article was sourced by fetching the primary document during a single production session (July 2026). No statistic is drawn from model memory or secondary-aggregator paraphrase without cross-referencing the original document.
Primary sources used:
- IDC Worldwide Wearable Device Tracker (idc.com/promo/wearablevendor/, updated March 25, 2026 and June 2025 APAC release)
- Counterpoint Research Global Smartwatch Shipments Tracker, Q4 2025 (February 2026; referenced via 9to5Mac, MacTech.com, and AppleMagazine citing the primary Counterpoint release)
- Garmin Ltd., SEC Annual Report (Form ARS, fiscal year ended December 27, 2025) — segment financials confirmed from EDGAR (SEC accession: 000119312526169264)
- Garmin Ltd., SEC Form 8-K filings Q1–Q4 2025 and Q4 2024 (EDGAR, all fetched and read)
- Shahid et al. (2025), “Diagnostic Accuracy of Apple Watch Electrocardiogram for Atrial Fibrillation: A Systematic Review and Meta-Analysis”, PMC11780081, npj Digital Medicine (February 2025 collection date; accepted December 2024)
- PMC12731301 (2025), “Diagnostic Accuracy of Wearable ECG Devices for Atrial Fibrillation and ST-Segment Changes: A Systematic Review”, PMC, December 2025
- Discovery Journals review on wearable devices and arrhythmia detection (citing Sibomana et al., 2025 PPG meta-analysis, 97.4% sensitivity/96.6% specificity)
- Rock Health 2025 Consumer Adoption of Digital Health Survey (n=8,000; results reported by Fierce Healthcare, June 2, 2026 — fetched and read)
- IDC Q1 2025 China/global wrist-worn press release (IDC China, June 24, 2025)
- Canalys newsroom: China wearable band market H1 2025 (canalys.com, fetched)
SWHI™ Formula and Limitations
The Smartwatch Health Integration Index (SWHI™, v1.0) is an Axis Intelligence Research original metric, formula detailed in the SWHI™ section above. Limitations:
- Clinical Validation Score uses a simplified per-brand regulatory-clearance count; it does not capture algorithmic accuracy differences within cleared features.
- Adoption Penetration Score uses global adult ownership and a 50% saturation ceiling — a conservative assumption; actual ceiling may be lower or higher depending on price trajectory.
- ECG Accuracy Score draws on a single meta-analysis (Shahid et al.) and does not pool results from competing meta-analyses, which show slightly different results by methodology.
- Health Use Rate relies on self-reported survey data from a US-centric sample (Rock Health); international use rates may differ.
- SWHI™ does not currently capture blood glucose or blood pressure monitoring accuracy, since no large peer-reviewed validation datasets comparable to the AFib literature exist for consumer smartwatches as of July 2026.
About This Dataset
The companion CSV (smartwatch-statistics-2026.csv) contains every quantitative claim in this article as a machine-readable row, with full provenance columns. It is released under CC BY 4.0.
License: Creative Commons Attribution 4.0 International (CC BY 4.0)
Citation: Axis Intelligence Research, “Smartwatch Statistics 2026,” axis-intelligence.com, July 2026
Dataset last updated: July 13, 2026
Cite this dataset:
APA: Axis Intelligence Research. (2026). Smartwatch Statistics 2026 [Dataset]. axis-intelligence.com. https://axis-intelligence.com/smartwatch-statistics/
MLA: Axis Intelligence Research. “Smartwatch Statistics 2026.” Axis Intelligence Research, 2026, axis-intelligence.com/smartwatch-statistics/.
Chicago: Axis Intelligence Research. “Smartwatch Statistics 2026.” Dataset. Axis Intelligence Research, 2026. https://axis-intelligence.com/smartwatch-statistics/.
Frequently Asked Questions
How many smartwatches were sold in 2025?
Global smartwatch shipments grew 4% year-over-year in 2025 to approximately 163–164 million units, recovering from a 7% decline in 2024, according to Counterpoint Research’s Global Smartwatch Shipments Tracker (Q4 2025). China was the primary driver, with government subsidies producing a 37.6% surge in wrist-worn device shipments in Q1 2025 alone (IDC, June 2025).
Which smartwatch brand has the highest market share?
Apple led global smartwatch unit shipments in 2025 with 23% market share, followed by Huawei at 17% and Xiaomi at 9%, per Counterpoint Research (February 2026 full-year data). For the first time in Q2 2025, Huawei briefly surpassed Apple in quarterly shipments before Apple’s portfolio refresh in September 2025 restored its lead.
How accurate is Apple Watch ECG for detecting atrial fibrillation?
A 2025 peer-reviewed meta-analysis (Shahid et al., PMC11780081, February 2025) found a pooled sensitivity of 94.8% and specificity of 95% for Apple Watch ECG in detecting atrial fibrillation across multiple studies. A separate 2024 meta-analysis of PPG-based wearables found 97.4% sensitivity. The primary real-world limitation is a ~10.7% rate of poor-quality or uninterpretable recordings.
How many people own a smartwatch in the United States?
The Rock Health 2025 Consumer Adoption of Digital Health Survey (n=8,000) found 43% of US adults reported owning a smartwatch, making it the most-owned connected health device. DemandSage and industry surveys place US smartwatch penetration at approximately 26% of all households.
What is Garmin’s smartwatch revenue?
Garmin’s Fitness segment — which includes smartwatches, cycling products, and activity trackers — generated $2.357 billion in revenue in fiscal year 2025, up 33% year-over-year, per Garmin’s SEC Annual Report (Form ARS, fiscal year ended December 27, 2025). Garmin does not break out smartwatch-only revenue within this segment.
Is the smartwatch market growing or shrinking in 2026?
IDC forecasts a modest 2.8% decline in global smartwatch shipments for full-year 2026, to 159.7 million units, citing memory-related supply constraints that push average selling prices higher and soften replacement demand, especially in price-sensitive markets (IDC Quarterly Wearable Device Tracker, March 25, 2026). The category is projected to return to modest growth from 2027 onward as supply conditions ease.
What is the Axis SWHI™ and what does the 2025 reading mean?
The Axis Smartwatch Health Integration Index (SWHI™) is a proprietary Axis Intelligence Research metric measuring how deeply smartwatches have integrated into clinical-grade health monitoring. The 2025 SWHI™ reading is 61.1 out of 100 — up from an estimated 53.1 in 2022 — reflecting meaningful progress in clinical validation (FDA-cleared features across Apple and Samsung), rising adoption, and near-diagnostic-grade ECG accuracy. The remaining gap to 100 largely reflects the concentration of regulated health features in premium-tier devices and the absence of validated blood glucose or blood pressure monitoring at consumer scale.
Why do different smartwatch market size estimates vary so widely?
Revenue estimates for 2025 range from approximately $35 billion (Statista, narrower digital health scope) to $48.4 billion (Global Market Insights, broader device ecosystem including accessories). The variation reflects three distinct methodological choices: which device types are included (smartwatches only vs. wristbands and kids’ watches), whether B2B and healthcare channels are counted, and whether average selling prices are calculated from retail vs. wholesale. Axis Intelligence Research anchors its analysis to verifiable primary-source signals — Garmin SEC filings, IDC unit forecasts, and Counterpoint share data — rather than selecting a single revenue estimate.